ImmunoGen, Inc.: capex
| Value | {"amount": 1708000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-07-01 – 2014-09-30 |
| Status | current |
| Entity | ImmunoGen, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:28:05.952928+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c002c6c4-0636-4a4a-b267-69a3074d1069
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-14-075205 · Open the official SEC filing →Retrieved: 2026-08-19T08:28:05.952928+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000855654/capex/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c002c6c4-0636-4a4a-b267-69a3074d1069
History
- no predecessors — first report